Status:
COMPLETED
Flupenthixol Decanoate in Methamphetamine Smoking - 1
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborating Sponsors:
Friends Research Institute, Inc.
Conditions:
Substance-Related Disorders
Eligibility:
All Genders
22-45 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the safety and efficacy of flupenthixol decanoate for treatment of methamphetamine dependence. Also, study will compare flupenthixol with desipramine in blocki...
Eligibility Criteria
Please contact site for information.
Key Trial Info
Start Date :
February 1 1994
Trial Type :
INTERVENTIONAL
End Date :
May 1 1996
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT00000241
Start Date
February 1 1994
End Date
May 1 1996
Last Update
January 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Friends Research Institute
Los Angeles, California, United States, 90025